Ly6C Hi Monocytes Delivering pH‐Sensitive Micelle Loading Paclitaxel Improve Targeting Therapy of Metastatic Breast Cancer

Advanced Functional Materials - United Kingdom
doi 10.1002/adfm.201904596
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Ultra-Thermostable RNA Nanoparticles for Solubilizing and High-Yield Loading of Paclitaxel for Breast Cancer Therapy

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2020English

Nab-Paclitaxel for the Management of Triple-Negative Metastatic Breast Cancer

Anti-Cancer Drugs
Cancer ResearchOncologyPharmacology
2015English

Oral Paclitaxel in the Treatment of Metastatic Breast Cancer (MBC) Patients.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2019English

P3-027Liver Cirrhosis Associated With Paclitaxel and Bevacizumab Combination Therapy in a Metastatic Breast Cancer Patient

Annals of Oncology
MedicineOncologyHematology
2018English

CRISPR-enhanced Engineering of Therapy-Sensitive Cancer Cells for Self-Targeting of Primary and Metastatic Tumors

Science Translational Medicine
Medicine
2018English

Reduction and pH Dual-Sensitive Nanovesicles Co-Delivering Doxorubicin and Gefitinib for Effective Tumor Therapy

RSC Advances
ChemistryChemical Engineering
2018English

How to Improve Endocrine Therapy of Breast Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1990English

Paclitaxel in Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
1998English

Immunoliposomal Delivery of 213Bi for -Emitter Targeting of Metastatic Breast Cancer

Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy